In re Ampicillin Antitrust Litigation’s Empirical Analysis
1972
Citation profile
2 federal appellate · 7 district · 5 state decisions
How this case has been cited
Cited by 29 later decisions — most recently October 2007 · most notably In re Nasdaq Market-Makers Antitrust Litigation (1996), In re Master Key Antitrust Litigation (1975)
2 federal appellate · 7 district · 5 state decisions
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Applies 15 U.S.C. § 12 (§ 1 of the Clayton Antitrust Act of 1914) · 15 U.S.C. § 15 (§ 4 of the Clayton Antitrust Act of 1914) · 15 U.S.C. § 15A (Sherman Antitrust Act) · 15 U.S.C. § 18 (§ 7 of the Clayton Antitrust Act of 1914) · 28 U.S.C. § 1407
Relies on Eisen v. Carlisle & Jacquelin · Kahan v. Rosenstiel · Miller v. Mackey International, Inc. · Philadelphia Electric Co. v. Anaconda American Brass Co. · State of West Virginia v. Chas. Pfizer & Co.
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.